Meiqi Shi
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 7
- Oncology top 10%
- Colorectal Cancer Treatments and Studies 11
- Cancer Immunotherapy and Biomarkers 10
- Lung Cancer Research Studies 10
- Cancer Treatment and Pharmacology 5
-
- Lung Cancer Treatments and Mutations 34
- Lung Cancer Diagnosis and Treatment 15
- Gastric Cancer Management and Outcomes 7
- Journals
- Journal of Clinical Oncology (11 papers)SHILAP Revista de lepidopterología (2 papers)Oncogene (1 paper)
- Partner nations
- ChinaPakistanUnited States
In The Last Decade
Meiqi Shi
61 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 364
- Oncology 448
- Pulmonary and Respiratory Medicine 393
- Molecular Biology 559
- Immunology 75
Countries citing papers authored by Meiqi Shi
This map shows the geographic impact of Meiqi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meiqi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meiqi Shi more than expected).
Fields of papers citing papers by Meiqi Shi
This network shows the impact of papers produced by Meiqi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meiqi Shi. The network helps show where Meiqi Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meiqi Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 0 | |
| 9 | 2021 | 4 | |
| 10 | 2020 | 15 | |
| 11 | 2020 | 55 | |
| 12 | 2020 | 8 | |
| 13 | 2019 | 13 | |
| 14 | 2019 | 7 | |
| 15 | 2018 | 6 | |
| 16 | 2017 | 5 | |
| 17 | 2017 | 55 | |
| 18 | 2017 | 1 | |
| 19 | 2015 | 2 | |
| 20 | 2010 | 64 |
About Meiqi Shi
Meiqi Shi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 70 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (34 papers), Lung Cancer Diagnosis and Treatment (15 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Lung Cancer Research Studies (10 papers), Cancer Genomics and Diagnostics (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Cancer Research (364 citations), Oncology (448 citations) and Pulmonary and Respiratory Medicine (393 citations). Meiqi Shi has collaborated with scholars based in China, Pakistan and United States. Frequent co-authors include Jifeng Feng, Shaorong Yu, Xiaobing Qin, Bo Shen, Muhammad Abbas, Siwen Liu, Leilei Zhou, Dali Yan, Yong Hu and Xiaoyue Xu. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.